investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors

Nathanael Schiander Gray

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Thomas W Valente

The Global Diffusion of Tobacco Control

Trachea, bronchus and lung

Ruth E Malone

Investigating Institutional Influences on Tobacco Control

Trachea, bronchus and lung

Munira Basrai

Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation

Trachea, bronchus and lung

Allan Weissman

Determining the Fate of Transmembrane Proteins

Trachea, bronchus and lung

Ethan Dmitrovsky

Targeting Anaphase Catastrophe to Combat Lung Cancer

Trachea, bronchus and lung

Bingliang Fang

Overcoming Resistance to Anti-EGFR Therapy by Drug Repurposing

Trachea, bronchus and lung

Deborah Morrison

Regulation of Ras-Dependent Signal Transduction Pathways

Trachea, bronchus and lung

Uwe Rix

Harnessing beneficial off-target effects of kinase inhibitors in lung cancer

Trachea, bronchus and lung

Pathology

Martin Mcintosh

Profiling cancer neoantigen repertoires and validating immunotherapy targets

Trachea, bronchus and lung